Drug Type Small molecule drug |
Synonyms Etopofos, Etoposide phosphate (USAN), BMY 40481 + [2] |
Target |
Mechanism Top II inhibitors(Topoisomerase II inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date US (17 May 1996), |
Regulation- |
Molecular FormulaC29H33O16P |
InChIKeyLIQODXNTTZAGID-OCBXBXKTSA-N |
CAS Registry117091-64-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D04107 | Etoposide Phosphate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Acute Myeloid Leukemia | CH | 09 Oct 2018 | |
Castration-Resistant Prostatic Cancer | CN | 09 Oct 2018 | |
Choriocarcinoma | CH | 09 Oct 2018 | |
Embryonal Carcinoma | CH | 09 Oct 2018 | |
Hodgkin's Lymphoma | BR | 09 Oct 2018 | |
Hodgkin's Lymphoma | CH | 09 Oct 2018 | |
Lung Cancer | CH | 09 Oct 2018 | |
Lymphoma | JP | 09 Oct 2018 | |
Non-Hodgkin Lymphoma | BR | 09 Oct 2018 | |
Non-Hodgkin Lymphoma | CH | 09 Oct 2018 | |
Small Cell Lung Cancer | US | 17 May 1996 | |
Testicular Neoplasms | US | 17 May 1996 |
Phase 1/2 | 7 | (Period 1: 35 mg/m^2/Dose BID PO Dasatinib x 17 Days) | muthcnovly(bdswzzbubr) = jmuzhquftg yylxaspbbs (ictbqbndqk, xwqoeykzag - fshcovcptd) | - | 27 Apr 2022 | ||
(Period 1: 35 mg/m^2 Dasatinib BID PO) | mtdrnofjqn(svggpqlcwc) = fshbpvymtm rqvdfrxboh (jzrghhqevt, amksnnrrzp - fcayvbztoq) View more | ||||||
Phase 2 | 164 | ABVD (Treatment (ABVD: 4 Cycles)) | wjarskuctc(zpgwrdjsuq) = mlvgfrarwu tdqcvfuxyc (jipgznnazh, tqsfvggbux - issmpopojs) View more | - | 14 Jun 2021 | ||
BEACOPP (Escalated BEACOPP and Involved Field Radiation Therapy) | gpryqkebet(vclbnyhxzp) = agvuxsphra klsldwnwps (sojvkkhqti, fuefxnabjz - fmsgdamgcw) View more | ||||||
Phase 3 | 1 | htctizzref(zqvdjzutju) = tnrlrgrypp zzpmwkgxwe (opvukcxujt, mutedelrep - lngxlaxmfk) View more | - | 24 Jun 2019 | |||
Phase 2 | 50 | xvdbmozocn(qmfalkfiai) = bubnpfrelu qhiytcmrfu (akxpadbrly, gacvwwwdui - zixgfzwnnr) View more | - | 11 Nov 2016 |